AZD9291 inactivates the PRC2 complex to mediate tumor growth inhibition

Deregulated Polycomb repressive complex 2 (PRC2) is intimately involved in tumorigenesis and progression, making it an invaluable target for epigenetic cancer therapy. Disrupting the EZH2–EED interaction, which is required for PRC2 enzymatic activity, is a promising strategy for cancer treatment. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Kai-li, Shen, Qian-qian, Fang, Yan-fen, Sun, Yi-ming, Ding, Jian, Chen, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468275/
https://www.ncbi.nlm.nih.gov/pubmed/31171828
http://dx.doi.org/10.1038/s41401-019-0248-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468275/
https://www.ncbi.nlm.nih.gov/pubmed/31171828
http://dx.doi.org/10.1038/s41401-019-0248-2

Ejemplares similares